2022
DOI: 10.1038/s41379-022-01067-x
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models

Abstract: Oral epithelial dysplasia (OED) is a precursor state usually preceding oral squamous cell carcinoma (OSCC). Histological grading is the current gold standard for OED prognostication but is subjective and variable with unreliable outcome prediction. We explore if individual OED histological features can be used to develop and evaluate prognostic models for malignant transformation and recurrence prediction. Digitised tissue slides for a cohort of 109 OED cases were reviewed by three expert pathologists, where t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
31
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(36 citation statements)
references
References 28 publications
1
31
1
Order By: Relevance
“…They have stated in their work that the lack of CD8 Tcells in non-cytotoxic subtype and non-immune reactive subtype can lead to progression in moderate and severe dysplasia. It is also interesting to note that our study has found binary grading to be a significant indicator for malignant transformation whereas the study performed by Dost et al 30 has shown no association between grading and transformation whereas Mahmood et al 32 showed associate between nuclear features and transformation. However, the nuclear features used corresponds to OED grading e.g., bulbus rete pegs, loss of epithelial cohesion etc., and upon adding histological grades into the mix they observed improvements in their results.…”
Section: Survival Analysiscontrasting
confidence: 47%
See 2 more Smart Citations
“…They have stated in their work that the lack of CD8 Tcells in non-cytotoxic subtype and non-immune reactive subtype can lead to progression in moderate and severe dysplasia. It is also interesting to note that our study has found binary grading to be a significant indicator for malignant transformation whereas the study performed by Dost et al 30 has shown no association between grading and transformation whereas Mahmood et al 32 showed associate between nuclear features and transformation. However, the nuclear features used corresponds to OED grading e.g., bulbus rete pegs, loss of epithelial cohesion etc., and upon adding histological grades into the mix they observed improvements in their results.…”
Section: Survival Analysiscontrasting
confidence: 47%
“…We have demonstrated that deep learning based weakly supervised IDaRS can predict malignant transformation with an AUROC of ~0.78 (±0.07 SD) on stratified 5-fold cross-validation using three different random seeds. Mahmood et al 32 also reported the AUROC of 0.77 for transformation using a similar but smaller cohort with the nuclear features subjectively assessed by three pathologists. The higher performance of IDaRS is because it dynamically learns important feature representations from the patches internally, as compared to fixed feature representation of a patch as an input limiting the learning possibilities of the model.…”
Section: Survival Analysismentioning
confidence: 90%
See 1 more Smart Citation
“…The use of these molecular markers in conjunction with other early clinical and histologic indicators may reliably predict disease progression [ 138 ]. The validation of prognostic models which significantly predict malignant transformation and recurrence based on specific histologic biomarkers (e.g., basal cell hyperplasia, loss of epithelial cohesion) has been successful and is ongoing [ 139 ]. Ultimately, validation of a prognostic scoring system incorporating molecular markers, clinical risk factors, and histologic grading will provide the greatest clinical utility.…”
Section: Conclusion and Clinical Applicationsmentioning
confidence: 99%
“…Similarly, studies have shown that deficiencies in DNA mismatch repair predict a positive response to immune checkpoint inhibition as well as platinum-based chemotherapies in HNSCC [ 140 , 141 ]. This is also true of cell cycle regulators, as amplification of cyclin D1 predicts cisplatin resistance, TP53 mutations predict susceptibility to G2-M cell cycle inhibitors [ 142 ], and Bcl-2 overexpression predicts radiotherapy failure with 71% accuracy [ 139 ]. Various therapeutic biomarkers, ranging from viral oncoproteins (e.g., HPV, EBV) and receptor tyrosine kinases (e.g., EGFR, PIK3CA) to immune checkpoint markers (e.g., PD-L1, PD-L2) and tumor suppressor proteins (e.g., TP53) have been identified as therapeutic targets in HNSCC [ 142 ].…”
Section: Conclusion and Clinical Applicationsmentioning
confidence: 99%